Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: Relation to clinical outcome

Journal of Neurology Neurosurgery and Psychiatry

Volumn 61, Issue 1, 1996, Pages 26-29

  Baird, A E ^a,c   Austin, M C ^b   McKay, W J ^b   Donnan, G A ^a,b,c  

^a Department of Neurology ^*  (Australia)

^b AUSTIN HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Computed tomography; Ischaemic stroke; Prognosis; Reperfusion; Stroke outcome

Indexed keywords

FIBRINOLYTIC AGENT; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

AGE; AGED; ARTICLE; BRAIN PERFUSION; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; REPERFUSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; TREATMENT OUTCOME;

EID: 0030036198     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.61.1.26     Document Type: Article

References (37)

1. Donnan GA, Davis SM, Chambers BR, et al. Australian streptokinase trial (ASK). In: del Zoppo GJ, Mori E, Hacke W, eds. Thrombolytic therapy in acute ischemic stroke II. Berlin: Springer-Verlag, 1993:80-5.
2. Pulsinelli W. Pathophysiology of acute ischaemic stroke. Lancet 1992;339:533-6.
3. Marchai G, Serrati C, Rioux P, et al. PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome. Lancet 1993;341: 925-7.
4. Baird AE, Donnan GA, Austin MC, Fitt GJ, Davis SM, McKay WJ. Reperfusion after thrombolytic therapy in ischemic stroke measured by single-photon emission computed tomography. Stroke 1994;25:79-85.
5. Herderscheê D, Limburg M, van Royen EA, Hijdra A, Büller HR, Koster PA. Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: evaluation with rCBF-SPECT. Acta Neurol Scand 1991;83:317-22.
6. Overgaard K, Sperling B, Boysen G, et al. Thrombolytic therapy in acute ischemic stroke. A Danish pilot study. Stroke 1993;24:1439-46.
7. Hanson SK, Grotta JC, Rhoades H, et al. Value of single-photon emission-computed tomography in acute stroke therapeutic trials. Stroke 1993;24:1322-9.
8. Chambers BR, Norris JW, Bette LS, Hachinski VC. Prognosis of acute stroke. Neurology 1987;37:221-5.
9. Biller J, Love BB, Marsh III E, et al. Spontaneous improvement after acute ischemic stroke. A pilot study. Stroke 1990;21:1008-12.
10. Lefkovits J, Davis SM, Rossiter SC, et al. Acute stroke outcome: effects of stroke type and risk factors. Aust NZ J Med 1992;22:30-5.
11. Censori B, Camerlingo M, Casto L, et al. Prognostic factors in first-ever stroke in the carotid artery territory seen within 6 hours after onset. Stroke 1993;24:532-5.
12. Oxbury JM, Greenhall RCD, Grainger KMR. Predicting the outcome of stroke: acute stage after cerebral infarction. BMJ 1975;3:125-7.
13. Brass LM, Rattner Z. SPECT imaging in cerebrovascular disease. Brain SPECT perfusion imaging: image acquisition, processing, display and interpretation. In: Proceedings of a workshop held at Brookhaven National Laboratory 8-9 October 1991:77-88.
14. Heiss W-D, Emunds H-G, Herholz K. Cerebral glucose metabolism as a predictor of rehabilitation after ischemic stroke. Stroke 1993;24:1784-8.
15. Chambers BR, Donnan GA, Bladin PF. Patterns of stroke. An analysis of the first 700 consecutive admissions to the Austin Hospital stroke unit. Aust NZ J Med 1983;13: 57-64.
16. Fitt GJ, Farrar JJ, Baird AE, et al. Pilot study of intra-arteriat streptokinase in acute ischaemic stroke. Med J Aust 1993;159:331-4.
17. Côté R, Battista RN, Wolfson C, Boucher J, Adam J, Hachinski V. The Canadian neurological scale: validation and reliability assessment. Neurology 1989;39: 638-43.
18. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md St Med J 1965;14:61-5.
19. Granger CV, Dewis LS, Peters NC, Sherwood CC, Barett JE. Stroke rehabilitation: analysis of repeated Barthel index measures. Arch Phys Med Rehabil 1979;60:14-7.
20. Marquardsen J. Natural history and prognosis of cerebrovascular disease. In: Ross Russell RW, ed. Cerebral arterial disease. Edinburgh: Churchill Livingstone, 1976: 24-39.
21. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Transactions on Nuclear Science 1978;NS-25:638-43.
22. Podreka I, Suess E, Goldenberg G, et al. Initial experience with technetium-99m HM-PAO brain SPECT. J Nucl Med 1987;28:1657-66.
23. Sperling B, Lassen NA. Hyperfixation of HMPAO during the subacute phase of stroke leading to spuriously high estimates of cerebral blood flow. Stroke 1993;24:193-4.
24. Adichie JN. Rank tests in linear models. In: Krishnaiah PR, Sen PK, eds. Handbook of statistics 4: non-parametric methods. Amsterdam: Elsevier Science Publishers BV, 1984: 229-57.
25. Jones TH, Morawetz RB, Crowell RM, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg 1981;54:773-82.
26. Siesjô BK. Pathophysiology and treatment of focal cerebral ischemia part I: pathophysiology. J Neurosurg 1992;77: 169-84.
27. Astrup J, Siesjš BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 1981;12: 723-5.
28. Kaplan B, Brint S, Tanabe J, Jacewicz M, Wang X, Pulsinelli W. Temporal thresholds for neocortical infarction in rats subjected to reversible focal cerebral ischemia. Stroke 1991;22:1032-9.
29. Crowell RM, Marcoux FW, DeGirolami U. Variability and reversibility of focal cerebral ischemia in unanesthetized monkeys. Neurology 1981;31:1295-302.
30. Heiss W-D, Huber M, Fink GR, et al. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab 1992;12:193-203.
31. Baron JC. Pathophysiology of acute cerebral ischemia: PET studies in humans. Cerebrovasc Dis 1991;1 (suppl 1): 22-31.
32. Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN, Thron A. Type and extent of hemisphere brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 1992;42: 289-98.
33. von Kummer R, Forsting M. Effects of recanalization and collateral blood supply on infarct extent and brain edema after middle cerebral artery occlusion. Cerebrovasc Dis 1993;3:252-5.
34. Warach S, Chien D, Li W, Ronthal M, Edelman RR. Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology 1992;42:1717-23.
35. Limburg M, van Royen EA, Hijdra A, Verbeeten B Jr. rCBF-SPECT in brain infarction: when does it predict outcome? J Nucl Med 1991;32:382-7.
36. Defer G, Moretti JL, Cesaro P, Sergent A, Raynaud C, Degos JD. Early and delayed SPECT using N-isopropyl p-iodoamphetamine iodine 123 in cerebral ischemia. A prognostic index for clinical recovery. Arch Neurol 1987; 44:715-8.
37. Lee RGL, Hill TC, Holman BL, Royal HD, O'Leary DH, Clouse ME. Predictive value of perfusion defect size using N-isopropyl-(I-123)-p-iodoamphetamine emission tomography in acute stroke. J Neurosurg 1984;61: 449-52.